Table 2 Kaplan-Meier estimates of survival probability according to main clinical-pathological variables for the 591 patients under study.
Data | Pts. | 5-yr overall survival | p value | 5-yr cancer-related survival | p value |
|---|---|---|---|---|---|
Age | Â | Â | <0.001 | Â | 0.011 |
≤67.5 years | 296 | 79.7% |  | 83.2% |  |
>67.5 years | 295 | 67.7% | Â | 75.2% | Â |
Gender | Â | Â | 0.019 | Â | 0.112 |
Male | 349 | 71% | Â | 77.7% | Â |
Female | 242 | 76.8% | Â | 81.6% | Â |
Tumor location | Â | Â | 0.917 | Â | 0.777 |
Colon | 444 | 73.7% | Â | 79.6% | Â |
Rectum | 38 | 72.7% | Â | 78.3% | Â |
Intent of surgery | Â | Â | <0.001 | Â | <0.001 |
R0 resection | 504 | 79.6% | Â | 85.9% | Â |
R1-2/No resection | 87 | 38% | Â | 39.7% | Â |
Depth of invasion (pT) | Â | Â | <0.001 | Â | <0.001 |
pTis | 62 | 91.4% | Â | 100% | Â |
pT1 | 91 | 85.1% | Â | 89.6% | Â |
pT2 | 69 | 84% | Â | 89.6% | Â |
pT3 | 227 | 75.8% | Â | 76.2% | Â |
pT4 | 137 | 51.5% | Â | 57.6% | Â |
Nodal involvement (pN) | Â | Â | <0.001 | Â | <0.001 |
pN0 | 350 | 86.1% | Â | 92.4% | Â |
pN1 | 152 | 63.9% | Â | 68.1% | Â |
pN2 | 84 | 40.2% | Â | 47.8% | Â |
Systemic metastasis (M) | Â | Â | <0.001 | Â | <0.001 |
M0 | 472 | 81.3% | Â | 87.9% | Â |
M1a | 84 | 46.6% | Â | 48.5% | Â |
M1b | 30 | — |  | — |  |
TNM stage | Â | Â | <0.001 | Â | <0.001 |
Stage 0-I | 175 | 92.6% | Â | 97.4% | Â |
Stage II | 155 | 80.8% | Â | 89.8% | Â |
Stage III | 142 | 68.5% | Â | 73.8% | Â |
Stage IV | 114 | 42.1% | Â | 43.8% | Â |
Histological type | Â | Â | 0.066 | Â | 0.218 |
Adenocarcinoma | 495 | 74.6% | Â | 80% | Â |
Mucinous | 82 | 70.3% | Â | 77.2% | Â |
Others | 14 | 42.9% | Â | 69.6% | Â |
Tumor grading | Â | Â | <0.001 | Â | <0.001 |
G1-G2 | 533 | 76.1% | Â | 81.7% | Â |
G3 | 58 | 41.7% | Â | 49.5% | Â |